Attract talent

Kinnate Biopharma



Kinnate Biopharma Inc. is focused on the discovery and development of small molecule kinase inhibitors for difficult-to-treat, genomically-defined cancers.


Add photos to showcase Kinnate Biopharma’s culture


Add Kinnate Biopharma’s values

Insider experiences

Share your experience of working at Kinnate Biopharma

Neha Krishnamohan
CFO & EVP, Corporate Development
Mark Meltz
COO & General Counsel
Eric Murphy
Chief Scientific Officer
Richard Williams
Chief Medical Officer
Ken Kobayashi
SVP, Clinical Development
Robert Kania
SVP, Drug Discovery
Sanjeev Thohan
VP, Non-Clinical Development
Jason Hampson
VP, Head of Regulatory Affairs
Barbara Warren
VP, People & Culture
Jason Cox
VP, Medicinal Chemistry
Clement Pimor
VP, Strategy & Portfolio Management

Add your teams to show how people work together at Kinnate Biopharma

Add jobs to your org chart to show candidates who they’ll work with

Publish company announcements to get more exposure

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.